首页> 外文OA文献 >Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

【2h】

Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

机译：诱导治疗的适当剂量降低对于治疗患有急性髓性白血病的婴儿是必不可少的：日本儿科白血病/淋巴瘤研究组的报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Daisuke Tomizawa; Akio Tawa; Tomoyuki Watanabe; Akiko Moriya Saito; Kazuko Kudo; Takashi Taga; Shotaro Iwamoto; Akira Shimada; Kiminori Terui; Hiroshi Moritake; Akitoshi Kinoshita; Hiroyuki Takahashi; Hideki Nakayama; Nobutaka Kiyokawa; Keiichi Isoyama; Shuki Mizutani; Junichi Hara; Keizo Horibe; Tatsutoshi Nakahata; Souichi Adachi;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: A report from the japanese pediatric leukemia/lymphoma study group [J] . TomizawaD., TawaA., WatanabeT., International journal of hematology . 2013,第5期

机译：日本小儿白血病/淋巴瘤研究组的报告：诱导治疗中适当降低剂量对于治疗急性髓样白血病至关重要
2. Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group [J] . Daisuke Tomizawa, Akio Tawa, Tomoyuki Watanabe, International Journal of Hematology . 2013,第5期

机译：日本小儿白血病/淋巴瘤研究小组的报告称，诱导治疗中适当减少剂量对于治疗急性髓样白血病至关重要
3. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group [J] . Matsuo Hidemasa, Nakamura Naomi, Tomizawa Daisuke, Pediatric blood & cancer . 2016,第8期

机译：CXCR4过表达是小儿急性髓样白血病低危险的预后因素：日本小儿白血病/淋巴瘤研究小组的报告
4. K-Means Clustering on 3^rd order polynomial based normalization of Acute Myeloid Leukemia (AML) and Acute Lymphocyte Leukemia (ALL) [C] . Mehdi A.M., Sehgal M.S., Zayegh A., Electrical Engineering, 2009. ICEE '09 . 2009

机译：基于3 ^{rd 多项式的K均值聚类基于急性髓细胞白血病（AML）和急性淋巴细胞白血病（ALL）的归一化}
5. Loss of Egr1 plays a role in murine leukemogenesis and may play a role in the development of acute myeloid leukemia and therapy-related acute myeloid leukemia. [D] . Joslin, John M. 2006

机译：Egr1的丢失在小鼠白血病的发生中起作用，并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
6. Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group [O] . Daisuke Tomizawa, Akio Tawa, Tomoyuki Watanabe, -1

机译：日本小儿白血病/淋巴瘤研究小组的报告称诱导治疗中适当降低剂量对于治疗急性髓性白血病的婴儿至关重要
7. OPEN ORIGINAL ARTICLE Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group [O] . H Nakayama 2016

机译：开放的原始文章CEBpa突变在小儿急性髓细胞白血病中的预后意义：日本儿科白血病/淋巴瘤研究组的报告

Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

著录项

相似文献

相关主题

期刊订阅